Selected Publications

Please click on topic for full list of publications and to download PDF files.

  • Tinklenberg, J.R., Kraemer, H.C., Yaffe, K., O’Hara, R., Ringman, J.M., Ashford, J.W., Yesavage, J.A., Taylor, J.L. Donepezil Treatment in Ethnically Diverse Patients with Alzheimer Disease. American Journal of Geriatric Psychiatry 23:4, 2015 (PDF)
 
  • Lazzeroni, L.C., Halbauer, J.D., Ashford, J.W., Noda, A., Hernandez, B., Azor, V., Hozack, N., Hasson, N., Henderson, V.W., Yesavage, J.A., Tinklenberg, J.R.. Memantine is Associated with Longer Survival than Donepezil in a Veterans Affairs Prescription Database. Journal of Alzheimer’s Disease 36(4):791-798, 2013 (PDF)
 
  • Winchester, J., Dick, M.B., Gillen, D., Reed, B., Miller, B., Tinklenberg, J.R., Mungus, D., Chui, H., Galasko, D., Hewett, L., Cotman, C.W. Walking stabilizes cognitive functioning in Alzheimer’s disease (AD) across one year. Archives of Gerontology and Geriatrics 56: 96–103, 2013 (PDF)
 
  • Yesavage, J.A., Noda, A., Hernandez, B., Friedman, L., Cheng, J.J., Tinklenberg, J.R., Hallmayer, J., O'Hara, R., David, R., Robert, P., Landsverk, E., Zeitzer, J.M. Circadian Clock Gene Polymorphisms and Sleep–Wake Disturbance in Alzheimer Disease. American Journal of Geriatric Psychiatry 19(7): 635-643, 2011 (PDF)
 
  • Tinklenberg, J.R., Kraemer, H.C., Yaffe, K., Ross, L., Sheikh, J., Ashford, J.W., Yesavage, J.A., Taylor, J.L.. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? American Journal of Geriatric Psychiatry 15(11):953-60, 2007. (PDF)
 
  • Ashford, J.W., Kraemer, H.C., Tinklenberg, J.R., O'Hara, R., Taylor, J.L., Yesavage, J.A.. Statistical and pharmacoeconomic issues for Alzheimer's screening. Alzheimers Dement, 3(2):126, 2007. (PDF)
 
  • Chuu, J.Y., Taylor, J.L., Tinklenberg, J.R., Noda, A., Yesavage, J.A., Murphy, Jr, G.M. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Rate of Decline in Alzheimer’s disease. Journal of Alzheimer’s Disease 9: 43–49, 2006 (PDF)
 
  • Huey, E.D., Taylor, J.L., Luu, P.A., Oehlert, J., Tinklenberg, J.R.. Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer's disease patients. Alzheimers Dement, 2(4):314-21, 2006. (PDF)

 

  • Hoblyn, J., Noda, A., Yesavage, J.A., Brooks, J.O. 3rd, Sheikh, J., Lee, T., Tinklenberg, J.R., Schneider, B., O'Hara, R., Leslie, D.L., Rosenheck, R.A., Kraemer, H.C. Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions. J Psychiatr Res,40(2):160-6, 2006. (PDF)
 
  • Aulakh, J.S., Hawkins, J.W., Athwal, H.S., Sheikh, J.I., Yesavage, J.A., Tinklenberg, J.R.. Tolerability and effectiveness of lamotrigine in complex elderly patients. J Geriatr Psychiatry Neurol, 18(1):8-11, 2005. (PDF)
 
  • Yesavage, J.A., Friedman, L., Kraemer, H., Tinklenberg, J.R., Salehi, A., Noda, A., Taylor, J.L., O'Hara, R., Murphy, G. Sleep/Wake Disruption in Alzheimer’s Disease: APOE Status and Longitudinal Course. J Geriatr Psychiatry Neurol 17: 20–24, 2004 (PDF)

 

  • Newkirk, L.A., Kim, J.M., Thompson, J.M., Tinklenberg, J.R., Yesavage, J.A., Taylor, J.L. Validation Of A 26-Point Telephone Version Of the Mini-Mental State Examination. Journal of Geriatric Psychiatry and Neurology 17: 80-87, 2004. (PDF)
 
  • Yesavage, J.A, Mumenthaler, M., Taylor, J.L., Friedman, L., O’Hara, R., Sheikh, J., Tinklenberg, J.R., Whitehouse, P.J. Donepezil and Flight Simulator Performance: Effects of Retention of Complex Skills. Neurology 59: 123-125, 2002. (PDF)
 
  • Murphy, G.M., Claassen, J.D., DeVoss, J.J., Pascoe, N., Taylor, J.L., Tinklenberg, J.R., Yesavage, J.A. Rate of cognitive decline in Alzheimer's Disease is accelerated by the interleukin-1a-889*1 allele. Neurology 56: 1595-7, 2001 (PDF)
 
  • Fama, R., Sullivan, E.V., Shear, P.K., Stein, M., Yesavage, J.A., Tinklenberg, J.R., Pfefferbaum, A. Extent, pattern, and correlates of remote memory impairment in Alzheimer’s Disease and Parkinson’s Disease. Neuropsychology, 14: 265-276, 2000. (PDF)
 
  • Fama, R., Sullivan, E.V., Shear, P.K., Cahn, D.A., Yesavage, J.A., Tinklenberg, J.R., Pfefferbaum, A. Fluency performance patterns in Alzheimer’s Disease and Parkinson’s Disease, The Clinical Neuropsychologist, 14: 29-40, 2000. (PDF)
 
  • Kahle, P.J., Murphy, G.M. Jr., Jakowec, M., Petzinger, G.M., Di Monte, D., Silverberg, G.D., Yesavage, J.A., Tinklenberg, J.R. and Shooter, E.M. Combined Assessment of Tau and Neuronal Thread Protein in Alzheimer Disease Cerebrospinal Fluid. Neurology, 54: 1498-1504, 2000.(PDF)
 
  • Dodel, R.C., Du, Y., Bales, K.R., Gao, F., Eastwood, B., Glazier, B., Zimmer, R., Cordel, B., Hecke, A., Evans, R., Gallagher-Thompson, D., Thompson, L.W., Tinklenberg, J.R., Pfefferbaum, A., Sullivan, E.V., Yesavage, J., Gasser, T., Farlow, M.R., Murphy, Jr., G.M., Paul, S.M. Alpha2 Macroglobulin and the Risk to Develop Alzheimer’s Disease. Neurology, 54: 438-444, 2000. (PDF)
 
  • Chui, H.C., Mack, W., Jackson, J.E., Mungas, D., Reed, B.R., Tinklenberg, J.R., Chang, F.L., Skinner, K., Tasaki, C., Jagust, W.J. Clinical Criteria for the Diagnosis of Vascular Dementia: A Multi-Center Study of Comparability and Inter-Rater Reliability. Archives of Neurology, 57: 191-196, 2000. (PDF)
 
  • Vaidya, C., Gabrieli, J.D. E., Monti, L.A., Tinklenberg, J.R., Yesavage, J.A. Dissociation Between Two Forms Of Conceptual Priming In Alzheimer’s Disease, Neuropsychology, 13: 516-534, 1999. (PDF)
 
  • Joseph, L., Wolfson, D.B., Bélisle, P., Brooks, J.O., Yesavage, J.A., Tinklenberg, J.R., Mortimer, J.A.: Taking account of between-patient hypervariability when modeling decline in Alzheimer’s Disease. American Journal of Epidemiology, 149: 963-973, 1999. 
 
  • Cahn, D.A., Sullivan, E.V., Shear, P.K., Fama, R., Lim, K.O., Tinklenberg, J.R., Yesavage, J.A., Pfefferbaum, A. Structural correlates of clock drawing performance in Alzheimer’s disease. Journal of the International Neuropsychological Society 5: 502-509, 1999. (PDF)
 
  • Davies, H.D. “Dementia and Delirium in the Elderly”. The Clinical Practice of Gerontological Nursing: An Advanced Text W.B. Saunders, Philadelphia, 1991, 2nd edition, 1998. (PDF)
 
  • Park, S.M., Gabrieli, J.D.E., Reminger, S.L., Monti, L.A., Fleischman, D.A., Wilson, R.S., Tinklenberg, J.R., Yesavage, J.A. Preserved priming across study-test picture transformations in patients with Alzheimer’s disease. Neuropsychology 12: 340-352, 1998. (PDF) 
 
  • Miller, T.P., Taylor, J., Rogerson, S., Mauricio, M., Kennedy, Q., Schatzberg, A., Tinklenberg, J., Yesavage, J. Cognitive and Noncognitive Symptoms in Dementia Patients: Relationship to Cortisol and Dehydroepiandrosterone. International Psychogeriatrics 10 (1): 85-96, 1998. (PDF)
 
  • Kraemer, H.C., Taylor, J.L., Tinklenberg, J.R., Yesavage, J.A. The Stages of Alzheimer’s Disease: A Reappraisal. Dementia and Geriatric Cognitive Disorders 9: 299-308, 1998. (PDF)
 
  • Murphy, G.M., Taylor, J., Kraemer H.C., Yesavage, J.A., Tinklenberg, J.R. No association between apolipoprotein E e4 allele and rate of decline in Alzheimer’s disease. American Journal of Psychiatry 154: 603-608, 1997. (PDF)
 
  • Ernst, R.L., Hay, J.W., Fenn, C., Tinklenberg, J.R., Yesavage, J.A. Cognitive function and the costs of Alzheimer’s Disease: An exploratory study. Archives of Neurology, 54 (6): 687-693, 1997. (PDF)
 
  • Murphy, G.M., Sullivan, E.V., Gallagher-Thompson, D., Thompson, L., Ellis, W.G., Jagust, W.J., Yesavage, J., Tinklenberg, J.R. No association between the Alpha 1-antichymotrypsin A allele and Alzheimer's disease. Neurology, 48 (5): 1313-1316, 1997. (PDF)
 
  • Murphy, G.M., Taylor, J., Tinklenberg, J.R., Yesavage, J.A. The Apolipoprotein e4 allelle is associated with increased behavioral disturbance in Alzheimer’s Disease. American Journal of Geriatric Psychiatry, 5 (1): 88-89, 1997. (PDF)
 
  • Ford, J.M., Roth, W.T., Isaacks, B.G., Tinklenberg, J.R., Yesavage, J.A., Pfefferbaum, A. Automatic and effortful processing in aging and dementia. Neurobiology of Aging, 18 (2): 169-180, 1997. (PDF) 
 
  • Kraemer, H.C., Tinklenberg, J.R., Yesavage, J.A. 'How far' vs. 'how fast' in Alzheimer's Disease. Archives of Neurology, 51: 275-279, 1994. (PDF)
 
  • Taylor, J.L., Miller, T.P., Tinklenberg, J.R. Correlates of Memory Decline: A four-year longitudinal study of older adults with memory complaints. Psychology and Aging, 7: 185-193, 1992. (PDF)